News
TIGIT-targeting therapies have largely disappointed in recent months, with failed studies, terminated partnerships and ...
GlaxoSmithKline has staked a claim to the fast-moving category of cancer therapies targeting the TIGIT immune checkpoint, agreeing a $2 billion plus licensing agreement with iTeos Therapeutics for ...
GSK, iTeos TIGIT drug belrestotug shows efficacy in PD-L1-high NSCLC trial at ESMO, giving some positive news for the beleaguered class.
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.
GSK's marketing application for linerixibat, targeting cholestatic pruritus in PBC patients, gains EMA acceptance based on phase III success.
Hosted on MSN17d
GSK faces Senator probe for pulling asthma inhaler in U.S. - MSNDemocratic U.S. Senator Maggie Hassan has reportedly launched an investigation into British pharmaceutical giant GSK's (NYSE:GSK) decision to pull the branded Flovent HFA asthma inhaler from the U ...
Nagpur: A blood donation and health check-up camp was organised on Saturday at the MIDC Industries Association (MIA) premises in Hingna, in a joint ef.
Researchers from Instituto de Investigación Sanitaria Hospital Universitario de La Princesa and collaborators have developed nanoparticles loaded with poly(I:C) and used them to prime monocyte-derived ...
By Ahmed Aboulenein WASHINGTON (Reuters) -Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results